Low Frequency of Second Autologous STEM CELL Transplantation (ASCT) for Multiple Myeloma (MM) Patients (PTS) Aged 65 YEARS and ABOVE in the Modern Era

Prajwol Pathak(University of Florida), Maxim Norkin(Centre Hospitalier Universitaire Vaudois), John R. Wingard(University of Florida Health), Fei Zou(University of Florida), John W. Hiemenz(University of Florida)
Transplantation and Cellular Therapy
February 18, 2016
Cited by 0


Related Papers